Brief: Rallybio Corporation And Candid Therapeutics Announce Merger Agreement

Rallybio

02/03/2026 13:24

March 2 (Reuters) - Rallybio Corp RLYB.O:

RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENT

RALLYBIO CORP - OVER $505 MILLION FINANCING COMMITTED BY INVESTORS

RALLYBIO CORP: COMBINED COMPANY'S CASH BALANCE AT CLOSING IS EXPECTED TO FUND OPERATIONS THROUGH 2030

RALLYBIO CORP: PRE-TRANSACTION RALLYBIO EQUITYHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 3.65% OF COMBINED CO

RALLYBIO CORP - KEN SONG TO LEAD COMBINED COMPANY AS CEO

RALLYBIO CORP - PRO-FORMA CASH OF ABOUT $700 MILLION EXPECTED AT CLOSING

Source text: ID:nBw1f6M4wa

Further company coverage: RLYB.O

 ((Reuters.Briefs@thomsonreuters.com;))